The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Extracellular vesicles and anti-cancer drug resistance
Open accessAbstract
Extracellular vesicles (EVs) including exosomes, microvesicles, oncosomes, and microparticles have been associated with communicating anti-cancer drug-resistance. The in vitro, pre-clinical in vivo and patients' data linking EVs to drug-resistance (and the specific drugs involved) in breast cancer, prostate cancer, lung cancer, ovarian cancer, haematological malignancies, colorectal cancer, gastric cancer, pancreatic cancer, glioblastoma, neuroblastoma, melanoma, kidney cancer and osteosarcoma. Details of the mechanisms by which the resistance seems to be occurring (e.g. EVs transferring drug-efflux pumps from drug-resistant cancer cells, EVs binding monoclonal antibodies in the peripheral circulation and so reducing their bioavailability, EVs from tumour microenvironment cells, etc.) are outlined, as are efforts to try to block such resistance. Research to date strongly supports EVs as playing a key role in drug-resistance. Further studies including tailored clinical studies are now warranted to determine how best to prevent this occurring, in the interest of patients and also for economic benefit. Furthermore, efforts to exploit safe (non-cancer origin) EVs as anti-cancer drug delivery vehicles that may achieve efficacy with more limited side-effects than free drug, deserve further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Proceedings of the National Academy of Sciences of the United States of America
Dowling, J. E., & Wald, G. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1981.tb06752.x · Cited by 17,893
Identification and expansion of human colon-cancer-initiating cells
Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., & De Maria, R. (2007) · Nature · doi:10.1038/nature05384 · Cited by 3,998
Johnstone, R. M., Adam, M., Hammond, J. R., Orr, L., & Turbide, C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48095-7 · Cited by 2,931
Qu, L., Ding, J., Chen, C., Wu, Z.-J., Liu, B., Gao, Y., Chen, W., Liu, F., Sun, W., Li, X.-F., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.004 · Cited by 1,117
Gardiner, C., Di Vizio, D., Sahoo, S., Théry, C., Witwer, K. W., Wauben, M., & Hill, A. F. (2016) · Journal of Extracellular Vesicles · doi:10.3402/jev.v5.32945 · Cited by 1,069
Jang, S. C., Kim, O. Y., Yoon, C. M., Choi, D.-S., Roh, T.-Y., Park, J., Nilsson, J., Lötvall, J., Kim, Y.-K., & Gho, Y. S. (2013) · ACS Nano · doi:10.1021/nn402232g · Cited by 1,022
The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling
Van Deun, J., Mestdagh, P., Sormunen, R., Cocquyt, V., Vermaelen, K., Vandesompele, J., Bracke, M., De Wever, O., & Hendrix, A. (2014) · Journal of Extracellular Vesicles · doi:10.3402/jev.v3.24858 · Cited by 938
Pascucci, L., Coccè, V., Bonomi, A., Ami, D., Ceccarelli, P., Ciusani, E., Viganò, L., Locatelli, A., Sisto, F., Doglia, S. M., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.042 · Cited by 846
Au Yeung, C. L., Co, N.-N., Tsuruga, T., Yeung, T.-L., Kwan, S.-Y., Leung, C. S., Li, Y., Lu, E. S., Kwan, K., Wong, K.-K., et al. (2016) · Nature Communications · doi:10.1038/ncomms11150 · Cited by 774
Maloney, D., Liles, T., Czerwinski, D., Waldichuk, C., Rosenberg, J., Grillo-Lopez, A., & Levy, R. (1994) · Blood · doi:10.1182/blood.v84.8.2457.2457 · Cited by 762
Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells
Richards, K. E., Zeleniak, A. E., Fishel, M. L., Wu, J., Littlepage, L. E., & Hill, R. (2017) · Oncogene · doi:10.1038/onc.2016.353 · Cited by 735
Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells.
Roninson, I. B., Chin, J. E., Choi, K. G., Gros, P., Housman, D. E., Fojo, A., Shen, D. W., Gottesman, M. M., & Pastan, I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4538 · Cited by 686
Kim, M. S., Haney, M. J., Zhao, Y., Yuan, D., Deygen, I., Klyachko, N. L., Kabanov, A. V., & Batrakova, E. V. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.09.011 · Cited by 663
Zheng, P., Chen, L., Yuan, X., Luo, Q., Liu, Y., Xie, G., Ma, Y., & Shen, L. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0528-y · Cited by 629
Saari, H., Lázaro-Ibáñez, E., Viitala, T., Vuorimaa-Laukkanen, E., Siljander, P., & Yliperttula, M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.031 · Cited by 613
Safaei, R., Larson, B. J., Cheng, T. C., Gibson, M. A., Otani, S., Naerdemann, W., & Howell, S. B. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0102 · Cited by 564
Milk-derived exosomes for oral delivery of paclitaxel
Agrawal, A. K., Aqil, F., Jeyabalan, J., Spencer, W. A., Beck, J., Gachuki, B. W., Alhakeem, S. S., Oben, K., Munagala, R., Bondada, S., et al. (2017) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2017.03.001 · Cited by 542
Potential role of HER2‐overexpressing exosomes in countering trastuzumab‐based therapy
Ciravolo, V., Huber, V., Ghedini, G. C., Venturelli, E., Bianchi, F., Campiglio, M., Morelli, D., Villa, A., Mina, P. D., Menard, S., et al. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.22773 · Cited by 514
Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine
Fais, S., O’Driscoll, L., Borras, F. E., Buzas, E., Camussi, G., Cappello, F., Carvalho, J., Cordeiro da Silva, A., Del Portillo, H., El Andaloussi, S., et al. (2016) · ACS Nano · doi:10.1021/acsnano.5b08015 · Cited by 481
Self-citationCorcoran, C., Rani, S., O’Brien, K., O’Neill, A., Prencipe, M., Sheikh, R., Webb, G., McDermott, R., Watson, W., Crown, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050999 · Cited by 448
Self-citationPancreatic Cancer Chemoresistance to Gemcitabine
Amrutkar, M., & Gladhaug, I. (2017) · Cancers · doi:10.3390/cancers9110157 · Cited by 448
Wang, J., Hendrix, A., Hernot, S., Lemaire, M., De Bruyne, E., Van Valckenborgh, E., Lahoutte, T., De Wever, O., Vanderkerken, K., & Menu, E. (2014) · Blood · doi:10.1182/blood-2014-03-562439 · Cited by 441
Chen, W.-X., Liu, X.-M., Lv, M.-M., Chen, L., Zhao, J.-H., Zhong, S.-L., Ji, M.-H., Hu, Q., Luo, Z., Wu, J.-Z., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095240 · Cited by 420
Takahashi, K., Yan, I. K., Kogure, T., Haga, H., & Patel, T. (2014) · FEBS Open Bio · doi:10.1016/j.fob.2014.04.007 · Cited by 376
Aung, T., Chapuy, B., Vogel, D., Wenzel, D., Oppermann, M., Lahmann, M., Weinhage, T., Menck, K., Hupfeld, T., Koch, R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102855108 · Cited by 374
Challagundla, K. B., Wise, P. M., Neviani, P., Chava, H., Murtadha, M., Xu, T., Kennedy, R., Ivan, C., Zhang, X., Vannini, I., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv135 · Cited by 359
Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells
Wei, Y., Lai, X., Yu, S., Chen, S., Ma, Y., Zhang, Y., Li, H., Zhu, X., Yao, L., & Zhang, J. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3037-0 · Cited by 354
Exosome Release and Low pH Belong to a Framework of Resistance of Human Melanoma Cells to Cisplatin
Federici, C., Petrucci, F., Caimi, S., Cesolini, A., Logozzi, M., Borghi, M., D'Ilio, S., Lugini, L., Violante, N., Azzarito, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088193 · Cited by 354
Hu, Y., Yan, C., Mu, L., Huang, K., Li, X., Tao, D., Wu, Y., & Qin, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0125625 · Cited by 348
Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells
Bebawy, M., Combes, V, Lee, E., Jaiswal, R., Gong, J., Bonhoure, A., & Grau, G. E. R. (2009) · Leukemia · doi:10.1038/leu.2009.76 · Cited by 322
ΔNp73, A Dominant-Negative Inhibitor of Wild-type p53 and TAp73, Is Up-regulated in Human Tumors
Zaika, A. I., Slade, N., Erster, S. H., Sansome, C., Joseph, T. W., Pearl, M., Chalas, E., & Moll, U. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020179 · Cited by 318
Exosomes Increase the Therapeutic Index of Doxorubicin in Breast and Ovarian Cancer Mouse Models
Hadla, M., Palazzolo, S., Corona, G., Caligiuri, I., Canzonieri, V., Toffoli, G., & Rizzolio, F. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0154 · Cited by 282
O’Brien, K., Lowry, M. C., Corcoran, C., Martinez, V. G., Daly, M., Rani, S., Gallagher, W. M., Radomski, M. W., MacLeod, R. A. F., & O’Driscoll, L. (2015) · Oncotarget · doi:10.18632/oncotarget.5192 · Cited by 273
Self-citationMikamori, M., Yamada, D., Eguchi, H., Hasegawa, S., Kishimoto, T., Tomimaru, Y., Asaoka, T., Noda, T., Wada, H., Kawamoto, K., et al. (2017) · Scientific Reports · doi:10.1038/srep42339 · Cited by 268
Patel, G. K., Khan, M. A., Bhardwaj, A., Srivastava, S. K., Zubair, H., Patton, M. C., Singh, S., Khushman, M., & Singh, A. P. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.18 · Cited by 266
Taylor, S., Spugnini, E. P., Assaraf, Y. G., Azzarito, T., Rauch, C., & Fais, S. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.08.004 · Cited by 259
Qin, X., Yu, S., Zhou, L., Shi, M., Hu, Y., Xu, X., Shen, B., Liu, S., Yan, D., & Feng, J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s131516 · Cited by 249
Wei, F., Ma, C., Zhou, T., Dong, X., Luo, Q., Geng, L., Ding, L., Zhang, Y., Zhang, L., Li, N., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0694-8 · Cited by 245
Exosomes derived from human mesenchymal stem cells confer drug resistance in gastric cancer
Ji, R., Zhang, B., Zhang, X., Xue, J., Yuan, X., Yan, Y., Wang, M., Zhu, W., Qian, H., & Xu, W. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1005530 · Cited by 233
Pink, R. C., Samuel, P., Massa, D., Caley, D. P., Brooks, S. A., & Carter, D. R. F. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.12.042 · Cited by 218
Resistance to combination BRAF and MEK inhibition in metastatic melanoma: Where to next?
Welsh, S. J., Rizos, H., Scolyer, R. A., & Long, G. V. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.04.005 · Cited by 217
Exosomes: Decreased Sensitivity of Lung Cancer A549 Cells to Cisplatin
Xiao, X., Yu, S., Li, S., Wu, J., Ma, R., Cao, H., Zhu, Y., & Feng, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089534 · Cited by 200
Heery, R., Finn, S., Cuffe, S., & Gray, S. (2017) · Cancers · doi:10.3390/cancers9040038 · Cited by 198
Caivano, A., Laurenzana, I., De Luca, L., La Rocca, F., Simeon, V., Trino, S., D’Auria, F., Traficante, A., Maietti, M., Izzo, T., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-3741-3 · Cited by 194
Ma, X., Chen, Z., Hua, D., He, D., Wang, L., Zhang, P., Wang, J., Cai, Y., Gao, C., Zhang, X., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400272111 · Cited by 180
Ma, X., Cai, Y., He, D., Zou, C., Zhang, P., Lo, C. Y., Xu, Z., Chan, F. L., Yu, S., Chen, Y., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202989109 · Cited by 179
Exosomal delivery of berry anthocyanidins for the management of ovarian cancer
Aqil, F., Jeyabalan, J., Agrawal, A. K., Kyakulaga, A.-H., Munagala, R., Parker, L., & Gupta, R. C. (2017) · Food & Function · doi:10.1039/c7fo00882a · Cited by 178
Davidoff, A. M. (2012) · Seminars in Pediatric Surgery · doi:10.1053/j.sempedsurg.2011.10.009 · Cited by 178
Wu, H., Zhou, J., Mei, S., Wu, D., Mu, Z., Chen, B., Xie, Y., Ye, Y., & Liu, J. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13056 · Cited by 172
Qu, Z., Wu, J., Wu, J., Luo, D., Jiang, C., & Ding, Y. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0430-z · Cited by 164
Chapuy, B., Koch, R., Radunski, U., Corsham, S., Cheong, N., Inagaki, N., Ban, N., Wenzel, D., Reinhardt, D., Zapf, A., et al. (2008) · Leukemia · doi:10.1038/leu.2008.103 · Cited by 162
Exosomes from docetaxel-resistant breast cancer cells alter chemosensitivity by delivering microRNAs
Chen, W., Cai, Y.-Q., Lv, M., Chen, L., Zhong, S., Ma, T.-F., Zhao, J., & Tang, J. (2014) · Tumor Biology · doi:10.1007/s13277-014-2242-0 · Cited by 158
Molina, A. M., Lin, X., Korytowsky, B., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.08.021 · Cited by 158
Multimodal transfer of MDR by exosomes in human osteosarcoma
Torreggiani, E., Roncuzzi, L., Perut, F., Zini, N., & Baldini, N. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3509 · Cited by 158
Exosomal Doxorubicin Reduces the Cardiac Toxicity of Doxorubicin
Toffoli, G., Hadla, M., Corona, G., Caligiuri, I., Palazzolo, S., Semeraro, S., Gamini, A., Canzonieri, V., & Rizzolio, F. (2015) · Nanomedicine · doi:10.2217/nnm.15.118 · Cited by 156
Kreger, B. T., Johansen, E., Cerione, R. A., & Antonyak, M. A. (2016) · Cancers · doi:10.3390/cancers8120111 · Cited by 152
Exosomes derived from mesenchymal non-small cell lung cancer cells promote chemoresistance
Lobb, R. J., van Amerongen, R. A., Wiegmans, A. P., Ham, S., Larsen, J. E., & Möller, A. (2017) · International Journal of Cancer · doi:10.1002/ijc.30752 · Cited by 146
Dl, Y., Bb, S., Liu, J., Wenyu, W., & Shu, Y.-Q. (2017) · PubMed · Cited by 141
Predictive role of GSTP1-containing exosomes in chemotherapy-resistant breast cancer
Yang, S., Wang, D., Li, J., Xu, H., Shen, H.-Y., Chen, X., Zhou, S., Zhong, S., Zhao, J., & Tang, J. (2017) · Gene · doi:10.1016/j.gene.2017.04.031 · Cited by 139
Martínez, V. G., O’Neill, S., Salimu, J., Breslin, S., Clayton, A., Crown, J. P., & O’Driscoll, L. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1362530 · Cited by 139
Self-citationLuciani, F., Molinari, A., Lozupone, F., Calcabrini, A., Lugini, L., Stringaro, A., Puddu, P., Arancia, G., Cianfriglia, M., & Fais, S. (2002) · Blood · doi:10.1182/blood.v99.2.641 · Cited by 138
Yin, J., Yan, X., Yao, X., Zhang, Y., Shan, Y., Mao, N., Yang, Y., & Pan, L. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01316.x · Cited by 133
Zeng, A.-L., Yan, W., Liu, Y.-W., Wang, Z., Hu, Q., Nie, E., Xin Min, Z. H. O. U., Li, R., Wang, X.-F., Jiang, T., et al. (2017) · Oncogene · doi:10.1038/onc.2017.134 · Cited by 129
Biomarkers and Multiple Drug Resistance in Breast Cancer
O’Driscoll, L., & CLYNES, M. M. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906777723958 · Cited by 128
Self-citationIessi, E., Logozzi, M., Lugini, L., Azzarito, T., Federici, C., Spugnini, E. P., Mizzoni, D., Raimo, R. D., Angelini, D. F., Battistini, L., et al. (2017) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2017.1292263 · Cited by 124
Exosomes as mediators of platinum resistance in ovarian cancer
Crow, J., Atay, S., Banskota, S., Artale, B., Schmitt, S., & Godwin, A. K. (2017) · Oncotarget · doi:10.18632/oncotarget.14440 · Cited by 123
UCH‐L1‐containing exosomes mediate chemotherapeutic resistance transfer in breast cancer
Ning, K., Wang, T., Sun, X., Zhang, P., Chen, Y., Jin, J., & Hua, D. (2017) · Journal of Surgical Oncology · doi:10.1002/jso.24614 · Cited by 123
Soldevilla, B., Rodríguez, M., Millán, C. S., García‐Barberán, V., Fernández-Periañez, R., Gil-Calderón, B., Martín, P., García‐Grande, A., Silva, J., Bonilla, F., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt437 · Cited by 116
Novel Extracellular Vesicles Mediate an ABCG2-Dependent Anticancer Drug Sequestration and Resistance
Ifergan, I., Scheffer, G. L., & Assaraf, Y. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2021 · Cited by 110
Yu, D., Wu, Y., Zhang, X., Lv, M., Chen, W., Chen, X., Yang, S., Shen, H., Zhong, S., Tang, J., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-4161-0 · Cited by 107
Zhang, F.-F., Zhu, Y., Zhao, Q., Yang, D., Dong, Y., Li, J., Xing, W.-X., Li, X., Xing, H., Shi, M., et al. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.05.026 · Cited by 106
Exosomes decrease sensitivity of breast cancer cells to adriamycin by delivering microRNAs
Mao, L., Li, J., Chen, W., Cai, Y.-Q., Yu, D., Zhong, S., Zhao, J., Zhou, J., & Tang, J. (2015) · Tumor Biology · doi:10.1007/s13277-015-4402-2 · Cited by 100
Bouvy, C., Wannez, A., Laloy, J., Chatelain, C., & Dogné, J.-M. (2017) · Leukemia Research · doi:10.1016/j.leukres.2017.09.014 · Cited by 99
Kong, J. N., He, Q., Wang, G., Dasgupta, S., Dinkins, M. B., Zhu, G., Kim, A., Spassieva, S. D., & Bieberich, E. (2015) · International Journal of Cancer · doi:10.1002/ijc.29542 · Cited by 97
Miyoshi, Y., Nakayama, S., Torikoshi, Y., Tanaka, S., Ishihara, H., Taguchi, T., Tamaki, Y., & Noguchi, S. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00202.x · Cited by 94
Patterns of care and survival for patients with glioblastoma multiforme diagnosed during 2006
Yabroff, K. R., Harlan, L., Zeruto, C. A., Abrams, J. S., & Mann, B. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nor218 · Cited by 92
Walsh, N., Larkin, A., Kennedy, S., Connolly, L., Ballot, J., Ooi, W., Gullo, G., Crown, J., Clynes, M., & O'Driscoll, L. (2009) · BMC Urology · doi:10.1186/1471-2490-9-6 · Cited by 88
Self-citationLarkin, A., O’Driscoll, L., Kennedy, S., Purcell, R. V., Moran, E., Crown, J. P., Parkinson, M. D., & CLYNES, M. M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20369 · Cited by 87
Self-citationExosome-derived microRNAs contribute to prostate cancer chemoresistance
Li, J., Yang, X., Guan, H., Mizokami, A., Keller, E. T., Xu, X., Liu, X., Tan, J., Hu, L., Lü, Y., et al. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3560 · Cited by 87
Exosome is a mechanism of intercellular drug transfer: Application of quantitative pharmacology
Wang, J., Yeung, B. Z., Cui, M., Peer, C. J., Lu, Z., Figg, W. D., Wientjes, M. G., Woo, S., & Au, J. L. ‐. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.10.020 · Cited by 85
Akao, Y., Khoo, F., Kumazaki, M., Shinohara, H., Miki, K., & Yamada, N. O. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15011392 · Cited by 78
Li, X., Liu, J.-T., Fan, L.-L., Liu, Y., Cheng, L., Wang, F., Yu, H., Gao, J., Wei, W., Wang, H., et al. (2016) · OncoTarget · doi:10.18632/oncotarget.8358 · Cited by 76
Vella, L. J., Behren, A., Coleman, B. M., Greening, D. W., Hill, A. F., & Cebon, J. S. (2017) · Neoplasia · doi:10.1016/j.neo.2017.07.002 · Cited by 70
Dong, Y., Pan, Q., Li, J., Chen, Z., Zhang, F.-F., Liu, Y., Xing, H., Shi, M., Li, J., Li, X., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.076 · Cited by 63
Choi, D., You, S., Jung, J. H., Lee, J. C., Rho, J. K., Lee, K. Y., Freeman, M. R., Kim, K. P., & Kim, J. (2014) · PROTEOMICS · doi:10.1002/pmic.201400008 · Cited by 54
Raji, G. R., Sruthi, T. V., Edatt, L., Haritha, K., Shankar, S. S., & Kumar, V. B. S. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.07.005 · Cited by 50
O’Driscoll, L., Daly, C., Saleh, M., et al. (1993) · Cytotechnology · doi:10.1007/bf00744669 · Cited by 46
Self-citationQin, X., Yu, S., Xu, X., Shen, B., & Feng, J. (2017) · Oncotarget · doi:10.18632/oncotarget.15009 · Cited by 46
Collins, D. M., Crown, J. P., O’Donovan, N., Devery, A., O’Sullivan, F., O’Driscoll, L., CLYNES, M. M., & O'Connor, R. A. (2009) · Investigational New Drugs · doi:10.1007/s10637-009-9266-0 · Cited by 44
Self-citationEl‐Sayed, I. Y., Daher, A., Destouches, D., Firlej, V., Kostallari, E., Maillé, P., Huet, E., Haidar-Ahmad, N., Jenster, G. W., TAILLE, A. D. L., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.09.010 · Cited by 43
Liang, Y., O’Driscoll, L., McDonnell, S., Doolan, P., Oglesby, I. K., Duffy, K., O'Connor, R. A., & CLYNES, M. M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20230 · Cited by 41
Self-citationPanagopoulos, K., Cross-Knorr, S., Dillard, C. M., Pantazatos, D., Tatto, M. D., Mills, D., Goldstein, L., Renzulli, J., Quesenberry, P. J., & Chatterjee, D. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-118 · Cited by 41
FLIM reveals alternative EV-mediated cellular up-take pathways of paclitaxel
Saari, H., Lisitsyna, E. S., Rautaniemi, K., Rojalin, T., Niemi, L., Nivaro, O., Laaksonen, T., Yliperttula, M. L., & Vuorimaa, E. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.06.015 · Cited by 41
MDR1/P-glycoprotein and MRP-1 mRNA and protein expression in non-small cell lung cancer.
Roy, S., Kenny, E., Kennedy, S., Larkin, A., Ballot, J., Villarreal, M. P. D., Crown, J. P., & O’Driscoll, L. (2007) · PubMed · Cited by 37
Self-citation
Cited by
Exosomes in cancer development, metastasis, and immunity
Zhang, L., & Yu, D. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.04.004 · Cited by 870
Inhibiting extracellular vesicles formation and release: a review of EV inhibitors
Catalano, M., & O'Driscoll, L. (2020) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2019.1703244 · Cited by 658
Self-citationExosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery
Antimisiaris, S. G., Mourtas, S., & Marazioti, A. (2018) · doi:10.20944/preprints201810.0507.v1 · Cited by 605
Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery
Antimisiaris, S. G., Mourtas, S., & Marazioti, A. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040218 · Cited by 603
The multi-factorial nature of clinical multidrug resistance in cancer
Assaraf, Y. G., Brozovic, A., Gonçalves, A. C., Jurkovicova, D., Linē, A., Machuqueiro, M., Saponara, S., Sarmento-Ribeiro, A. B., Xavier, C. P. R., & Vasconcelos, M. H. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100645 · Cited by 528
Metadata
- Authors
- Namee, N. M., & O'Driscoll, L.
- Venue
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Publisher
- Elsevier BV
- Published
- 2018-12
- Volume
- 1870
- Issue
- 2
- Pages
- 123-136
- ISSN
- 0304-419X (ISSN-L)
- OpenAlex
- W2858674133
- Cited by
- 274
- References
- 94
- FWCI
- 8.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.